Amikacin-250 mg (2 ml) Injection | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare



Amikacin-250 mg (2 ml) Injection — manufactured by Trumac Healthcare

Amikacin-250 mg (2 ml) Injection

WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India

Salt: Amikacin-250 mg (2 ml)
Form: Injection
Class: Aminoglycoside Antibiotic
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ 1 Brand Options

Pricing, brochure & monopoly territory within 24 hrs.

Our Amikacin-250 mg (2 ml) Injection Brand Options (1 option)

Trumac Healthcare manufactures and supplies the following Amikacin-250 mg (2 ml) Injection brands for PCD pharma distribution. Click any brand to view full specifications and packaging.

Amikacin-250 mg (2 ml) Injection is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Amikacin-250 mg (2 ml) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.

Therapeutic Indications
  • Serious gram-negative bacterial infections — septicaemia, complicated UTI
  • Hospital-acquired pneumonia and ventilator-associated pneumonia
  • Complicated intra-abdominal infections (with beta-lactam)
  • Skin, soft tissue and post-surgical infections
  • Empirical therapy in febrile neutropenia
  • Adjunct in multi-drug-resistant tuberculosis
Mechanism of Action

Amikacin binds irreversibly to the 30S bacterial ribosomal subunit, causing mRNA misreading and inhibition of protein synthesis. The resulting non-functional proteins damage bacterial cell membranes, producing rapid bactericidal effect. Activity is concentration-dependent with a long post-antibiotic effect supporting once-daily dosing.

Dosage & Administration
  • Adults: 15 mg/kg/day, typically given as a single daily dose by IM injection or slow IV infusion.
  • Dose adjustment required in renal impairment based on serum levels.
  • Treatment duration typically 7–10 days.
Side Effects
  • Nephrotoxicity, ototoxicity (cochlear and vestibular), neuromuscular blockade.
  • Local injection site pain.
  • Less commonly: hypersensitivity, rash, transient hepatic enzyme elevation.
Contraindications
  • Hypersensitivity to aminoglycosides.
  • Concomitant nephrotoxic/ototoxic drugs without monitoring.
  • Pre-existing 8th cranial nerve damage.
  • Myasthenia gravis.
  • Pregnancy (Category D).
  • Therapeutic drug monitoring strongly advised in renal impairment.
Storage

Store below 25 °C, protected from light. Do not freeze.

PCD Pharma Franchise for Amikacin-250 mg (2 ml) Injection

  • ✓ WHO-GMP certified manufacturing facility
  • ✓ Pan-India monopoly distribution rights available
  • ✓ Multiple pack sizes: Vial
  • ✓ Trade-friendly PTR / PTS margins
  • ✓ Free promotional material on request
  • ✓ Full DCGI documentation and quality certificates supplied

Trumac Healthcare offers 1 brand option for Amikacin-250 mg (2 ml) Injection — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.

For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Amikacin-250 mg (2 ml) Injection, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.

Frequently Asked Questions

Who is the manufacturer of Amikacin-250 mg (2 ml) Injection?

Trumac Healthcare is a WHO-GMP certified manufacturer of Amikacin-250 mg (2 ml) Injection in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.

Is Amikacin-250 mg (2 ml) Injection available for PCD pharma franchise on monopoly basis?

Yes. We offer Amikacin-250 mg (2 ml) Injection for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.

What pack sizes are available for Amikacin-250 mg (2 ml) Injection?

Available pack sizes include: Vial.

What is the MRP / trade price for Amikacin-250 mg (2 ml) Injection?

MRPs range from ₹85 to ₹85 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.

How do I place an order or franchise enquiry?

WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.

Ready to start your PCD franchise for Amikacin-250 mg (2 ml) Injection?

Get Pricing & Franchise Terms →